106 related articles for article (PubMed ID: 9296232)
1. Toleration of intravenous azithromycin.
Luke DR; Foulds G
Ann Pharmacother; 1997 Sep; 31(9):965-9. PubMed ID: 9296232
[TBL] [Abstract][Full Text] [Related]
2. Safety, toleration, and pharmacokinetics of intravenous azithromycin.
Luke DR; Foulds G; Cohen SF; Levy B
Antimicrob Agents Chemother; 1996 Nov; 40(11):2577-81. PubMed ID: 8913468
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.
Chandra R; Liu P; Breen JD; Fisher J; Xie C; LaBadie R; Benner RJ; Benincosa LJ; Sharma A
Clin Pharmacokinet; 2007; 46(3):247-59. PubMed ID: 17328583
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue tolerance of azithromycin after intramuscular administration to rabbits.
Escudero E; Fernández-Varón E; Marín P; Espuny A; Nájera MD; Cárceles CM
Res Vet Sci; 2006 Dec; 81(3):366-72. PubMed ID: 16530237
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
[TBL] [Abstract][Full Text] [Related]
6. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
[TBL] [Abstract][Full Text] [Related]
7. Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial.
Pokharel S; Basnyat B; Arjyal A; Mahat SP; Kc RK; Bhuju A; Poudyal B; Kestelyn E; Shrestha R; Phuong DNT; Thapa R; Karki M; Dongol S; Karkey A; Wolbers M; Baker S; Thwaites G
Trials; 2017 Oct; 18(1):450. PubMed ID: 28969659
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intravenously administered azithromycin in pediatric patients.
Jacobs RF; Maples HD; Aranda JV; Espinoza GM; Knirsch C; Chandra R; Fisher JM; Kearns GL
Pediatr Infect Dis J; 2005 Jan; 24(1):34-9. PubMed ID: 15665708
[TBL] [Abstract][Full Text] [Related]
9. Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.
Protzko E; Bowman L; Abelson M; Shapiro A;
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3425-9. PubMed ID: 17652708
[TBL] [Abstract][Full Text] [Related]
10. Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease.
Brown BA; Griffith DE; Girard W; Levin J; Wallace RJ
Clin Infect Dis; 1997 May; 24(5):958-64. PubMed ID: 9142801
[TBL] [Abstract][Full Text] [Related]
11. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial.
Luft BJ; Dattwyler RJ; Johnson RC; Luger SW; Bosler EM; Rahn DW; Masters EJ; Grunwaldt E; Gadgil SD
Ann Intern Med; 1996 May; 124(9):785-91. PubMed ID: 8610947
[TBL] [Abstract][Full Text] [Related]
13. No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers.
Purkins L; Wood N; Ghahramani P; Kleinermans D; Layton G; Nichols D
Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):30-6. PubMed ID: 14616411
[TBL] [Abstract][Full Text] [Related]
14. Venous irritation related to intravenous administration of phenytoin versus fosphenytoin.
Jamerson BD; Dukes GE; Brouwer KL; Donn KH; Messenheimer JA; Powell JR
Pharmacotherapy; 1994; 14(1):47-52. PubMed ID: 8159601
[TBL] [Abstract][Full Text] [Related]
15. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial.
Equi A; Balfour-Lynn IM; Bush A; Rosenthal M
Lancet; 2002 Sep; 360(9338):978-84. PubMed ID: 12383667
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
[TBL] [Abstract][Full Text] [Related]
17. A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media.
Arguedas A; Emparanza P; Schwartz RH; Soley C; Guevara S; de Caprariis PJ; Espinoza G
Pediatr Infect Dis J; 2005 Feb; 24(2):153-61. PubMed ID: 15702045
[TBL] [Abstract][Full Text] [Related]
18. Intravenous azithromycin-induced ototoxicity.
Bizjak ED; Haug MT; Schilz RJ; Sarodia BD; Dresing JM
Pharmacotherapy; 1999 Feb; 19(2):245-8. PubMed ID: 10030778
[TBL] [Abstract][Full Text] [Related]
19. Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia.
Kobbernagel HE; Buchvald FF; Haarman EG; Casaulta C; Collins SA; Hogg C; Kuehni CE; Lucas JS; Omran H; Quittner AL; Werner C; Nielsen KG
BMC Pulm Med; 2016 Jul; 16(1):104. PubMed ID: 27450411
[TBL] [Abstract][Full Text] [Related]
20. A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men.
Gajjar DA; LaCreta FP; Uderman HD; Kollia GD; Duncan G; Birkhofer MJ; Grasela DM
Pharmacotherapy; 2000 Jun; 20(6 Pt 2):49S-58S. PubMed ID: 10850521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
